Fundz

VectorY Therapeutics Appoints Olga Uspenskaya-Cadoz as Chief Medical Officer

PRIVATEApr 01, 2025

Position

Chief Medical Officer

Company

VectorY

Olga Uspenskaya-Cadoz
BiotechnologyHealth CareTherapeutics

Description

VectorY Therapeutics has announced the appointment of Dr. Olga Uspenskaya-Cadoz as Chief Medical Officer. This strategic hire aims to strengthen the company's clinical leadership as they prepare for a significant investigational new drug application for VTx-002 by the end of 2025.

Quick answer

VectorY Therapeutics Appoints Olga Uspenskaya-Cadoz as Chief Medical Officer (April 1, 2025).

Who is the new Chief Medical Officer at VectorY?
VectorY named Olga Uspenskaya-Cadoz Chief Medical Officer, announced April 1, 2025.
What did VectorY announce on April 1, 2025?
VectorY Therapeutics has announced the appointment of Dr. Olga Uspenskaya-Cadoz as Chief Medical Officer. This strategic hire aims to strengthen the company's clinical leadership as they prepare for a significant investigational new drug application for VTx-002 by the end of 2025.
What does VectorY do?
VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases.
Which similar companies made leadership changes around the same time?
Repare Therapeutics (April 1, 2025), Cantargia AB (April 1, 2025), Geneoscopy (April 2, 2025) and Verrica (March 26, 2025) also announced leadership changes within 45 days of VectorY.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at VectorY, and when

A new leader at VectorY brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day VectorY raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VectorY, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VectorY. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VectorY

About

VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases. With R&D and manufacturing facilities in Amsterdam, VectorY develops proprietary & partnered programs based on its novel AAV-based vectorized antibody & gene therapy platform. Product candidates are based on new vector technologies, which will enable the next generation of highly scalable manufacturing processes within VectorY’s own manufacturing facilities. Our manufacturing capabilities will include a state-of-the-art multi-product GMP facility in the Netherlands, with the capability to deliver suspension based AAV viral vector manufacturing of up to 2000L for both clinical and commercial supply.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VectorY changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sander van
Likely contact at this company
••••••••@••••••••

See Sander van's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for VectorY's next move

Learn about Strategic plan

VectorY changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.